Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Di Bella

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cell Death Discovery|April 26, 2025
Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patientsAlice Turdo, Gabriele Tulone, Sebastiano Di Bella, et al.
Biomolecules|January 25, 2025
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal MelanomaMichele Massimino, Elena Tirrò, Stefania Stella, et al.
Cell Death Discovery|March 30, 2026
Humic substances enhance the anti-cancer efficacy of standard therapiesPaola Bianca, Chiara Modica, Mariavittoria Verrillo, et al.
Molecular Cancer|April 1, 2025
C1Q<sup>+</sup> TPP1<sup>+</sup> macrophages promote colon cancer progression through SETD8-driven p53 methylationVeronica Veschi, Francesco Verona, Sebastiano Di Bella, et al.
Nature Communications|March 11, 2023
Recapitulating thyroid cancer histotypes through engineering embryonic stem cellsVeronica Veschi, Alice Turdo, Chiara Modica, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cell Death Discovery|April 26, 2025
Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patientsAlice Turdo, Gabriele Tulone, Sebastiano Di Bella, et al.
Biomolecules|January 25, 2025
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal MelanomaMichele Massimino, Elena Tirrò, Stefania Stella, et al.
Cell Death Discovery|March 30, 2026
Humic substances enhance the anti-cancer efficacy of standard therapiesPaola Bianca, Chiara Modica, Mariavittoria Verrillo, et al.
Molecular Cancer|April 1, 2025
C1Q<sup>+</sup> TPP1<sup>+</sup> macrophages promote colon cancer progression through SETD8-driven p53 methylationVeronica Veschi, Francesco Verona, Sebastiano Di Bella, et al.
Nature Communications|March 11, 2023
Recapitulating thyroid cancer histotypes through engineering embryonic stem cellsVeronica Veschi, Alice Turdo, Chiara Modica, et al.
Pageof 3